FDA — authorised 23 August 2013
- Application: NDA202317
- Marketing authorisation holder: HELSINN
- Status: supplemented
FDA authorised Valchlor on 23 August 2013
Yes. FDA authorised it on 23 August 2013; FDA has authorised it.
HELSINN holds the US marketing authorisation.